Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.
Section Overview

Therapeutic Area

Metabolic

Cardiovascular

Oncology

Respiratory

Inflammation
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.
See all products

Products

Metabolic

View

Champs Opens in new tab

Empagliflozin

Linagliptin

Inflamation

View

Nintedanib

Oncology

View

Giotrif

Cardiovascular

View

Dabigatran etexilate

Telmisartan

Respiratory

View

Tiotropium + Olodaterol
Resources
Contact
Logout

Boehringer Ingelheim

Not all DPP4i are the same - Dosing

Author: Boehringer Ingelheim

Author: Boehringer Ingelheim

Document ID: PC-SG-102336

Therapeutic Area

Resources

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Singapore. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.

Copyright © 2024 Boehringer Ingelheim Singapore Pte. Ltd.
All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement.